Published in Vaccine Weekly, April 11th, 2001
According to a new study from Theta Reports, New York, more than 15 new immunotherapy medicines have come to market in the past two years and at least 25 products are in late stage clinical trials. Furthermore, at least 400 vaccine products are in various earlier stages of development.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly